Dr Reddy's Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended December 31, 2022. The drug firm had reported a net profit of Rs 706 crore in the October-December period of the previous fiscal. Revenue from operations rose to Rs 6,770 crore during the period under review as against Rs 5,320 crore in the year-ago period, Dr Reddy's Laboratories said in a regulatory filing.
The total income in the December quarter of FY23 stood at Rs 15,967.16 crore, up 27.82 per cent from Rs 12,491.52 crore YoY
Indian staffing firm TeamLease Services Ltd on Wednesday reported a drop in quarterly profit hurt by slowing revenue growth and higher expenses.
Bajaj Auto on Wednesday said its consolidated net profit increased 3 per cent to Rs 1,473 crore in the third quarter ended December 31, 2022, aided by sales growth in the domestic market. The Pune-based company had reported a net profit of Rs 1,430 crore for October-December period a year ago. Total revenue from operations rose to Rs 9,319 crore in the quarter under review from Rs 9,022 crore in the year-ago period. The company said its total sales across domestic and export markets stood at 9,83,276 units in the third quarter as compared with 11,81,361 units in the same period last fiscal, a dip of 17 per cent. In the domestic market, the company reported sales of 5,44,188 units, up 4 per cent from 5,23,299 units in the year-ago period. Exports, however dropped 33 per cent to 4,39,088 units as against 6,58,062 units in October-December period of last fiscal. "On exports, macro-economic challenges continue to subdue industry volumes across overseas geographies. While the company
Drug major Cipla on Wednesday reported a 7 per cent increase in its consolidated net profit to Rs 808 crore for the third quarter ended December 2022, aided by robust sales. The Mumbai-based drug maker had reported a net profit of Rs 757 crore for the October-December period of the last fiscal. Its total revenue from operations rose to Rs 5,810 crore for the third quarter compared to Rs 5,479 in the year-ago period, Cipla said in a regulatory filing. For the nine months ended December 31, 2022, the company reported a net profit of Rs 2,311 crore against Rs 2,176 crore in the same period last fiscal. Shares of the company were trading 2.73 per cent down at Rs 1,032.50 apiece on the BSE.
Domestic demand is expected to improve sequentially in 4Q, supported by better rural market sentiment on the back of strong rabi crop sowing and higher MSPs.
The loss in the books was a result of adoption of stringent accounting practices by the Company due to continued shortfall in collections from one of the major customers, the company said.
Realty firm Macrotech Developers Ltd on Tuesday reported a 41 per cent increase in its consolidated net profit at Rs 404.98 crore for the quarter ended December. Its net profit stood at Rs 286.38 crore in the year-ago period, the company said in a regulatory filing. However, the total income fell to Rs 1,902.44 crore in the third quarter of this fiscal year from Rs 2,155.70 crore in the corresponding period of the previous year. Macrotech Developers, which is one of the leading real estate firms in the country, markets its properties under the Lodha brand. It focuses on Mumbai Metropolitan Region (MMR) and Pune -- the two biggest property markets in Maharashtra. It has recently forayed into the Bengaluru residential market.
UCO Bank on Tuesday reported more than two-fold jump in profit at Rs 653 crore for the quarter ended December 2022, driven by increase in interest income and decline in bad loans. Its net profit stood at Rs 310 crore in the same quarter of the preceding financial year. Total income increased to Rs 5,451 crore in the quarter from Rs 4,638 crore in the year-ago period, the bank said in a regulatory filing. At the same time, interest income rose to Rs 4,627 crore as compared to Rs 3,919 crore in the same quarter a year ago. On the asset quality front, the bank recorded an improvement with gross NPAs (Non-Performing Assets) declining to 5.63 per cent of gross advances as compared to 8 per cent at the end of the third quarter of 2021-22. Net NPAs too eased to 1.66 per cent from 2.81 per cent in the same quarter a year ago. As a result, provision for bad loans declined significantly to Rs 220 crore from Rs 565 crore in the same period a year ago. However, the capital adequacy ratio de
Dip in impairment losses and bad debts suppports performance, stock dips on company missing street estimates
Favourable forex variation, softening commodity prices and higher non-operating income drive performance, consolidated revenue jumps 26.9% to Rs 29,918 crore
Diageo-controlled liquor maker United Spirits on Tuesday said its consolidated net profit declined by 27 per cent to Rs 214 crore in the third quarter ended December 31, 2022. The company had reported a net profit of Rs 295 crore in the October-December quarter of last fiscal. Total income declined to Rs 6,631 crore for the period under review as against Rs 8,917 crore in the year-ago period, United Spirits said in a regulatory filing. For the nine months ended December 31, 2022, the Bengaluru-based company reported a net profit of Rs 1,023 crore as compared with Rs 632 crore in the year-ago period. Total income declined to Rs 22,079 crore as against Rs 23,306 crore in the April-December period of last financial year, it said. "We delivered a good quarter in an extremely volatile environment, carefully navigating through the route to market changes and input commodity cost inflation," United Spirits Managing Director & CEO Hina Nagarajan said. This is the first quarter post the .
Axis Bank Q3 result review: Axis Bank's is moving in the right direction with improvement in net interest margins, sustaining loan growth momentum, and expansion in return profile, analysts said
Strides Pharma Science on Tuesday reported a consolidated net loss of Rs 82 crore for the third quarter ended December 31, 2022. The drug firm had reported a net loss of Rs 127 crore in the October-December quarter of previous fiscal. Revenue from operations rose to Rs 865 crore for the quarter under review as against Rs 794 crore in the year-ago period, the company said in a regulatory filing. On a standalone basis, the company reported a net profit of Rs 12 crore as against a net loss of Rs 18 crore in the year-ago period, it added. The Bengaluru-based firm said the profit during the quarter was impacted by loss from JV and associates on account of inventory write off related to Covid portfolio. "We continue to focus on a profitable outcome for the business and have, by design, let go of several low margin businesses," Strides Pharma Science Founder, Managing Director and Executive Chairperson Arun Kumar said.
The toothpaste major's revenue from operations stood at Rs 1,281.2 crore
In comparison, the housing finance company (HFC) had booked a net profit of Rs 188 crore in the December quarter of FY22 and Rs 263 crore in the September quarter of FY23
Pidilite, known for its synthetic resin adhesive Fevicol and waterproofing product Dr. Fixit, reported a 4.7% rise in cost of raw materials
Operating EBITDA grows 16% to Rs 659 crore, EBITDA margin flat at 10.1%
Profit for the nine months ended December 31, 2022 was flat at Rs 1,048 crore
TVS', which operates in 80 countries including South Africa, Argentina and Sri Lanka, revenue from operations rose to Rs 6,545 crore from Rs 5,706 crore